Related Experiment Video

Updated: Jun 3, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

Are Additional Lipid Measures Useful?

Ryan D Bradley, Erica B Oberg

    Integrative Medicine (Encinitas, Calif.)
    |April 5, 2011
    PubMed

    Insights

    Traditional cholesterol levels don't always predict heart attack risk. Emerging biomarkers may improve cardiovascular disease risk assessment, but optimal lipid levels remain the primary focus for patient care.

    Area of Science:

    • Cardiovascular Medicine
    • Clinical Chemistry

    Background:

    • Total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) are primary indicators for coronary artery disease (CAD) risk.
    • However, a significant portion of myocardial infarction (MI) patients exhibit normal cholesterol levels, indicating limitations in traditional markers.

    Purpose of the Study:

    • To evaluate the utility of emerging biomarkers in refining cardiovascular risk stratification beyond traditional lipid panels.
    • To assess the clinical significance of novel markers in predicting CAD and guiding treatment decisions.

    Main Methods:

    • Review of emerging biomarkers including LDL particle characteristics, lipoprotein(a), apolipoproteins, C-reactive protein, and lipoprotein-associated phospholipase A(2).
    • Comparison of the predictive accuracy of these novel markers against traditional risk factors for CAD.

    Main Results:

    • Emerging biomarkers demonstrate potential to enhance cardiovascular risk assessment, offering greater accuracy than traditional factors in some patient groups.
    • These novel markers may be particularly useful for high-risk individuals and those with borderline traditional risk factors.

    Conclusions:

    • While novel biomarkers show promise for improved cardiovascular risk stratification, current treatment strategies should prioritize optimizing established lipid levels (LDL-C, HDL-C, TGs).
    • Further research is needed to establish treatment protocols that specifically target emerging biomarkers and demonstrate improved cardiovascular outcomes.

    Related Concept Videos

    Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

    Blood Studies for Cardiovascular System III: Serum Lipid Profile

    Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
    Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
    Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
    Lipid-derived Compounds in the Human Body01:31

    Lipid-derived Compounds in the Human Body

    Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
    Fat-soluble Vitamins
    Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
    Lipids as Anchors01:32

    Lipids as Anchors

    In the plasma membrane, the lipids forming the bilayer can also act as an anchor to tether proteins to the membrane. The three main types of lipid anchors found in eukaryotes are – prenyl groups, fatty acyl groups, and glycosylphosphatidylinositol or GPI groups. Prenyl and fatty acyl groups act as anchors on the cytosolic surface of the membrane, whereas GPI anchors proteins on the extracellular side.
    The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains the...
    Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

    Lipid-Lowering Drugs: Statins and Miscellaneous Agents

    Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...